合成生物学市場：ツール、技術、最終用途別-2025-2030年の世界予測

合成生物学市場は、2023年に138億8,000万米ドルと評価され、2024年には166億1,000万米ドルに達すると予測され、CAGR 21.33％で成長し、2030年には537億6,000万米ドルに達すると予測されています。

合成生物学は、生物学、工学、コンピュータサイエンス、化学の要素を組み合わせて、新しい生物学的部品、装置、システムを設計・構築したり、既存のものを有用な目的のために改良したりする学際的な分野です。合成生物学の必要性は、耐病性作物の創出による農業、薬剤生産や個別化医療のための人工生物によるヘルスケア、汚染物質を分解する生物の開発による環境管理など、さまざまな分野に革命をもたらす可能性にあります。その応用範囲は、人工微生物がバイオマスを効率的にエネルギーに変換するバイオ燃料生産や、化学物質、材料、酵素を生産する産業分野にも及ぶ。最終用途の範囲は、世界の課題に対する革新的な解決策を模索する学界、調査機関、多くの営利産業にまで広がっています。

合成生物学市場の主な成長促進要因としては、遺伝子工学技術の進歩、バイオテクノロジー研究への投資の増加、持続可能で環境に優しいソリューションに対する需要の高まりなどが挙げられます。精密医療やオーダーメイド治療への関心の高まりが、市場の進展をさらに後押ししています。現在のビジネスチャンスは、学術機関とバイオテクノロジー企業とのコラボレーション、CRISPR技術の拡大、バイオデザインプロセス改善のための人工知能の統合に焦点を当てています。これらを活用するために、利害関係者は研究開発への投資を優先し、戦略的パートナーシップを築き、規制状況を促進するために政策立案者と関わるべきです。しかし、倫理的な懸念、潜在的なバイオセキュリティリスク、研究開発コストの高さといった課題が大きな障壁となっています。また、予測不可能な結果をもたらしかねない生物学的システムの複雑さも、市場の成長を妨げています。

ゲノム合成、リアルタイムモニタリングのためのバイオセンサーの開発、宇宙探査における合成生物学の役割など、最先端のイノベーションが考えられています。スケーラブルな合成バイオ製造技術に投資することで、経済性が大幅に向上する可能性があります。合成生物学市場は、ダイナミックな成長、絶え間ないイノベーション、分野を超えた激しいコラボレーションを特徴としています。成功するためには、企業は適応力を維持し、規制機関との継続的な対話を行い、倫理基準を確実に守りながら特定の社会的ニーズに対応するブレークスルーに焦点を当てるべきです。

市場力学：急速に進化する合成生物学市場の主要な市場インサイトを公開

合成生物学市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 新薬およびワクチン開発への利用の増加
  • 合成生物学ベースのポイントオブケア診断機器の拡大
  • 様々な産業用途における合成生物学の需要拡大
• 市場抑制要因
  • 合成生物学技術の使用に伴うリスク
• 市場機会
  • 遺伝子編集および次世代シーケンサーの技術的進歩
  • 合成生物学アプリケーション拡大のための研究開発資金と投資の増加
• 市場の課題
  • 合成生物学による生物学的部品のモジュール化・標準化の制約

ポーターの5つの力：合成生物学市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、合成生物学市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：合成生物学市場における外部からの影響の把握

外部マクロ環境要因は、合成生物学市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析合成生物学市場における競合情勢の把握

合成生物学市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス合成生物学市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、合成生物学市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨合成生物学市場における成功への道筋を描く

合成生物学市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新薬やワクチン開発への利用増加
    • 合成生物学ベースのポイントオブケア診断デバイスの拡張
    • さまざまな産業用途における合成生物学の需要の加速
  • 抑制要因
    • 合成生物学テクノロジーの使用に伴うリスク
  • 機会
    • 遺伝子編集と次世代シーケンシングの技術進歩
    • 合成生物学アプリケーションの拡大に向けた研究開発資金と投資の増加
  • 課題
    • 生物部品のモジュール化と標準化における合成生物学の制約
• 市場セグメンテーション分析
  • ツール：合成生物学におけるイノベーションを推進するための必須ツールの探索
  • 最終用途：最終用途産業の変革における合成生物学の台頭
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 合成生物学市場ツール別

• DNAツール
• 一般的なツール
• 数学モデリングとコンピュータ支援設計ツール
• タンパク質ツール
• RNAツール

第7章 合成生物学市場：技術別

• バイオインフォマティクス
• 細胞配列解析
• 細胞合成と組み立て
• クローン
• マイクロ流体
• ナノテクノロジー
• オミックス技術
• 部位特異的変異誘発

第8章 合成生物学市場：最終用途別

• 農業
• 化粧品・パーソナルケア
• エネルギーと天然資源
• 環境
  • バイオレメディエーション
  • バイオセンシング
• 飲食品
• ヘルスケア・医薬品
  • 人工組織と組織再生
  • 創薬と治療
• 紙・繊維

第9章 南北アメリカの合成生物学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の合成生物学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの合成生物学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アシモフとiGEMが協力して合成生物学の未来のリーダーを育成
  • NRELは、合成生物学を通じてバイオ燃料のイノベーションを加速するために主要機関と提携しています。
  • モデナ社、日本のゲノム科学企業オリチロ社の買収によりmRNAの能力を拡大
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Amyris, Inc.
• Arzeda
• Batavia Biosciences B.V.
• Beam Therapeutics
• Beckman Coulter, Inc.
• BGI Genomics Co., Ltd.
• Codexis, Inc.
• Conagen, Inc.
• Creative Enzymes
• DNA TwoPointO Inc.
• Editas Medicine, Inc.
• Eurofins Scientific
• GenScript Biotech Corporation
• Ginkgo Bioworks, Inc.
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Merck KGaA
• New England Biolabs GmbH
• Novozymes A/S
• Precigen, Inc.
• QIAGEN N.V.
• Sangamo Therapeutics
• Scarab Genomics, LLC
• Synlogic
• Synthego Corporation
• TeselaGen Service
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation

LIST OF FIGURES

• FIGURE 1. SYNTHETIC BIOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. SYNTHETIC BIOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SYNTHETIC BIOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SYNTHETIC BIOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY DNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GENERAL TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MATHEMATICAL MODELLING & COMPUTER-AIDED DESIGN TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY RNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SYNTHESIS & ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY OMICS TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENERGY & NATURAL RESOURCES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER & TEXTILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 52. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 53. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 56. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 79. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 80. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 83. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 84. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 85. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 88. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 118. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 123. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 128. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 132. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 133. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 143. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 144. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 148. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 149. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 154. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 158. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 159. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 163. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 164. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 168. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 169. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 170. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 171. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 173. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 174. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 178. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 179. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 183. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 184. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 188. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 189. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 190. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 191. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 193. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 194. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 195. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 196. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 198. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 199. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 203. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 204. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 208. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 209. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 218. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 219. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 223. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 224. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 228. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 229. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 233. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 234. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 244. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 245. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 246. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Synthetic Biology Market was valued at USD 13.88 billion in 2023, expected to reach USD 16.61 billion in 2024, and is projected to grow at a CAGR of 21.33%, to USD 53.76 billion by 2030.

Synthetic biology is an interdisciplinary field that combines elements of biology, engineering, computer science, and chemistry to design and construct new biological parts, devices, and systems or to modify existing ones for useful purposes. The necessity of synthetic biology lies in its potential to revolutionize various sectors, such as agriculture, by creating disease-resistant crops; healthcare, through engineered organisms for drug production and personalized medicine; and environmental management, by developing organisms that can break down pollutants. Its application extends to biofuel production, where engineered microbes efficiently convert biomass into energy, and the industrial sector for producing chemicals, materials, and enzymes. The end-use scope extends to academia, research institutions, and a host of commercial industries seeking innovative solutions to global challenges.

Key growth drivers for the synthetic biology market include advancements in genetic engineering technologies, increased investment in biotech research, and a rising demand for sustainable and eco-friendly solutions. The burgeoning interest in precision medicine and tailored therapies further propels market advancements. Present opportunities focus on collaborations between academic institutions and biotech firms, expansion of CRISPR technology, and the integration of artificial intelligence for improved bio-design processes. To capitalize on these, stakeholders should prioritize investments in R&D, forge strategic partnerships, and engage with policy-makers to foster conducive regulatory landscapes. However, challenges such as ethical concerns, potential biosecurity risks, and high R&D costs pose significant barriers. Market growth is also hampered by the complexities of biological systems which can result in unpredictable outcomes.

Cutting-edge innovations are being contemplated in genome synthesis, the development of biosensors for real-time monitoring, and synthetic biology's role in space exploration. Investing in scalable synthetic bio-manufacturing technologies could significantly boost economic viability. The synthetic biology market is characterized by dynamic growth, continuous innovation, and intense collaboration across disciplines. To thrive, businesses should remain adaptable, engage in ongoing dialogue with regulatory bodies, and focus on breakthroughs that address specific societal needs while ensuring ethical standards are upheld.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Synthetic Biology Market

The Synthetic Biology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use for novel drug and vaccines development
  • Expansion of synthetic biology based point-of-care diagnostics devices
  • Accelerating demand for synthetic biology in various industrial applications
• Market Restraints
  • Risks associated with the use of synthetic biology technology
• Market Opportunities
  • Technological advancements in gene editing and next generation sequencing
  • Rising R&D funding and investments for expansion of synthetic biology applications
• Market Challenges
  • Constraints of synthetic biology in modularization and standardization of biological parts

Porter's Five Forces: A Strategic Tool for Navigating the Synthetic Biology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Synthetic Biology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Synthetic Biology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Synthetic Biology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Synthetic Biology Market

A detailed market share analysis in the Synthetic Biology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Synthetic Biology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Synthetic Biology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Synthetic Biology Market

A strategic analysis of the Synthetic Biology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Synthetic Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Batavia Biosciences B.V., Beam Therapeutics, Beckman Coulter, Inc., BGI Genomics Co., Ltd., Codexis, Inc., Conagen, Inc., Creative Enzymes, DNA TwoPointO Inc., Editas Medicine, Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs GmbH, Novozymes A/S, Precigen, Inc., QIAGEN N.V., Sangamo Therapeutics, Scarab Genomics, LLC, Synlogic, Synthego Corporation, TeselaGen Service, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Synthetic Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Tools, market is studied across DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools, Protein Tools, and RNA Tools.
• Based on Technology, market is studied across Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly, Cloning, Microfluidics, Nanotechnology, Omics Technologies, and Site-directed Mutagenesis.
• Based on End-Use, market is studied across Agriculture, Cosmetics & Personal Care, Energy & Natural Resources, Environment, Food & Beverage, Healthcare & Pharmaceuticals, and Paper & Textile. The Environment is further studied across Bioremediation and Biosensing. The Healthcare & Pharmaceuticals is further studied across Artificial Tissue & Tissue Regeneration and Drug Discovery & Therapeutics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use for novel drug and vaccines development
    • 5.1.1.2. Expansion of synthetic biology based point-of-care diagnostics devices
    • 5.1.1.3. Accelerating demand for synthetic biology in various industrial applications
  • 5.1.2. Restraints
    • 5.1.2.1. Risks associated with the use of synthetic biology technology
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in gene editing and next generation sequencing
    • 5.1.3.2. Rising R&D funding and investments for expansion of synthetic biology applications
  • 5.1.4. Challenges
    • 5.1.4.1. Constraints of synthetic biology in modularization and standardization of biological parts
• 5.2. Market Segmentation Analysis
  • 5.2.1. Tools: Exploring essential tools for powering innovations in synthetic biology
  • 5.2.2. End-Use: Rise of synthetic biology in transforming end-use industries
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Synthetic Biology Market, by Tools

• 6.1. Introduction
• 6.2. DNA Tools
• 6.3. General Tools
• 6.4. Mathematical Modelling & Computer-aided Design Tools
• 6.5. Protein Tools
• 6.6. RNA Tools

7. Synthetic Biology Market, by Technology

• 7.1. Introduction
• 7.2. Bioinformatics
• 7.3. Cell Sequencing
• 7.4. Cell Synthesis & Assembly
• 7.5. Cloning
• 7.6. Microfluidics
• 7.7. Nanotechnology
• 7.8. Omics Technologies
• 7.9. Site-directed Mutagenesis

8. Synthetic Biology Market, by End-Use

• 8.1. Introduction
• 8.2. Agriculture
• 8.3. Cosmetics & Personal Care
• 8.4. Energy & Natural Resources
• 8.5. Environment
  • 8.5.1. Bioremediation
  • 8.5.2. Biosensing
• 8.6. Food & Beverage
• 8.7. Healthcare & Pharmaceuticals
  • 8.7.1. Artificial Tissue & Tissue Regeneration
  • 8.7.2. Drug Discovery & Therapeutics
• 8.8. Paper & Textile

9. Americas Synthetic Biology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Synthetic Biology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Synthetic Biology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Asimov and iGEM Collaborate to Nurture Future Leaders in Synthetic Biology
  • 12.3.2. NREL Partners with Leading Institutions to Accelerate Biofuel Innovations through Synthetic Biology
  • 12.3.3. Moderna Expands mRNA Capabilities with Acquisition of Japanese Genomics Firm Oriciro
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Amyris, Inc.
• 3. Arzeda
• 4. Batavia Biosciences B.V.
• 5. Beam Therapeutics
• 6. Beckman Coulter, Inc.
• 7. BGI Genomics Co., Ltd.
• 8. Codexis, Inc.
• 9. Conagen, Inc.
• 10. Creative Enzymes
• 11. DNA TwoPointO Inc.
• 12. Editas Medicine, Inc.
• 13. Eurofins Scientific
• 14. GenScript Biotech Corporation
• 15. Ginkgo Bioworks, Inc.
• 16. Illumina, Inc.
• 17. Integrated DNA Technologies, Inc.
• 18. Merck KGaA
• 19. New England Biolabs GmbH
• 20. Novozymes A/S
• 21. Precigen, Inc.
• 22. QIAGEN N.V.
• 23. Sangamo Therapeutics
• 24. Scarab Genomics, LLC
• 25. Synlogic
• 26. Synthego Corporation
• 27. TeselaGen Service
• 28. Thermo Fisher Scientific Inc.
• 29. Twist Bioscience Corporation